Moleculin Biotech (MBRX) announced the pricing of a public offering consisting of 16,080,000 shares of common stock and Series E warrants to purchase up to 48,240,000 shares of its common stock, at a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback